Akros Monthly Financial Statements From 2010 to 2024
| MPAY Etf | USD 23.51 0.25 1.07% |
Check Akros Monthly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akros main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Akros financial statements analysis is a perfect complement when working with Akros Monthly Valuation or Volatility modules.
Akros |
Akros Monthly Payout ETF Price To Book Analysis
Akros Monthly's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Akros Monthly Price To Book | 60.00 X |
Most of Akros Monthly's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akros Monthly Payout is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Akros Monthly Payout has a Price To Book of 60 times. This is much higher than that of the Cabana family and significantly higher than that of the Moderate Allocation category. The price to book for all United States etfs is notably lower than that of the firm.
Akros Monthly Payout Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Akros Monthly's current stock value. Our valuation model uses many indicators to compare Akros Monthly value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Akros Monthly competition to find correlations between indicators driving Akros Monthly's intrinsic value. More Info.Akros Monthly Payout is rated number one ETF in price to earning as compared to similar ETFs. It is rated number one ETF in price to book as compared to similar ETFs . Comparative valuation analysis is a catch-all model that can be used if you cannot value Akros Monthly by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Akros Monthly's Etf. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Akros Monthly's earnings, one of the primary drivers of an investment's value.About Akros Monthly Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Akros Monthly income statement, its balance sheet, and the statement of cash flows. Akros Monthly investors use historical funamental indicators, such as Akros Monthly's revenue or net income, to determine how well the company is positioned to perform in the future. Although Akros Monthly investors may use each financial statement separately, they are all related. The changes in Akros Monthly's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Akros Monthly's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Akros Monthly Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Akros Monthly. Please read more on our technical analysis and fundamental analysis pages.
The fund normally invests in securities comprising the index. Akros Monthly is traded on NYSEARCA Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Akros Monthly Correlation against competitors. Note that the Akros Monthly Payout information on this page should be used as a complementary analysis to other Akros Monthly's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
The market value of Akros Monthly Payout is measured differently than its book value, which is the value of Akros that is recorded on the company's balance sheet. Investors also form their own opinion of Akros Monthly's value that differs from its market value or its book value, called intrinsic value, which is Akros Monthly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akros Monthly's market value can be influenced by many factors that don't directly affect Akros Monthly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akros Monthly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akros Monthly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akros Monthly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.